Prognostic Value of Complement Component 2 and Its Correlation with Immune Infiltrates in Hepatocellular Carcinoma

Figure 5

The most significant 30 KEGG pathways enriched in HCC patients with higher C2 expression compared to HCC patients with lower C2 expression of the TCGA cohort (a), GSE14520 cohort (b), and ICGC cohort (c).

(a)

(b)

(c)